Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-07-09
2010-10-12
Graser, Jennifer E (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S185100, C424S190100, C435S007100, C435S007320, C530S350000
Reexamination Certificate
active
07811585
ABSTRACT:
The present invention relates to antigens, more particularly an antigen ofStreptococcus pyogenes(also called group AStreptococcus(GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
REFERENCES:
patent: 7247308 (2007-07-01), Martin et al.
patent: 0916726 (1999-05-01), None
patent: WO 02/04495 (2002-01-01), None
Greenspan et al (Nature Biotechnology 7: 936-937, 1999).
Chothia et al (The EMBO Journal, 1986, 5/4:823-26).
Database EMBL/Genbank/DDBJ ′Online! EBI; Aug. 5, 1994, “42 KDa protein (ORF1) and 67 KDa myosin-crossreactive streptococcal antigen gene, complete cds,” XP002194339, Acc. No. SP09352.
Database Swall ′Online! EBI; Jun. 1, 2001, “Putative 42 KDa protein of S. pyogenes (encoded by gene spy0469),” XP002194340, Acc. No. Q9A147.
Database Swall ′Online! EBI; Nov. 1, 1996, “42 KDa protein (ORFI) and 67 KDa myosin-crossreactive streptococcal antigen,” XP002194338, Acc. No. Q54524.
Kil et al., “Cloning and Sequence Analysis of a Gene Encoding a 67-Kilodalton Myosin-Cross-Reactive Antigen ofStreptococcus pyogenesReveals Its Similarity with Class II Major Histocompatibility Antigens,”Infection and Immunity62(6): 2440-2449, Jun. 1994.
Mikayama et al., “Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor,”Proc. Natl. Acad. Sci. USA 90: 10056-10060, Nov. 1993.
Rudinger, “Characteristics of the amino acids as components of a peptide hormone sequence,”Peptide Hormones Biol. Council, pp. 5-7, Jun. 1976.
Hopp, “Retrospective: 12 Years of Antigenic Determinant Predictions, and More,”Peptide Research 6(4):183-190, 1993.
Jameson et al., “The antigenic index: a novel algorithm for predicting antigenic determinants,”Computer Application Bioscience 4(1):181-186, 1988.
Kolaskar et al., “A semi-empirical method for prediction of antigenic determinants on protein antigens,”FEBS 276(1,2): 172-174, 1990.
Menéndez-Arias et al., “A Basic microcomputer program for prediction of B and T cell epitopes in proteins,”Comput. Appl. Biosci. 6(2):101-105, 1990.
Boyer Martine
Brodeur Bernard
Hamel Josee
Martin Denis
Rioux Stephane
Graser Jennifer E
ID Biomedical Corporation
Seed IP Law Group PLLC
LandOfFree
Streptococcus pyogenes antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Streptococcus pyogenes antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Streptococcus pyogenes antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4182229